In an interview with Russian Ambassador to Moldova Oleg Vasnetsov, Moldovan President Maia Sandu said that her priority task was to ensure access of citizens of the country to the vaccine against coronavirus “as many species as possible.”
Moldova wants to get help from Russia for the fastest possible access to the Russian vaccine against the Sputnik V coronavirus. This was stated by the President of Moldova Maia Sandu during a meeting with the Ambassador of the Russian Federation to Moldova Oleg Vasnetsov, reported her press office on March 25.
“The priority now is to ensure that our citizens have access to as many types of effective vaccines as possible. We reiterated, as in other discussions, that we want to get help from the Russian Federation for faster access to the Sputnik V vaccine, given the need to speed up the process The sooner we ensure public access to the COVID-19 vaccine, the sooner we will have a chance to return to normal life and save the lives of our loved ones, “she said.
In Moldova, by data American Johns Hopkins University, coronavirus was confirmed in almost 220 thousand people, 4661 patients died, 193.6 thousand cases recovered.
Vaccination against cornavirus in Moldova started on March 2. At that time, the country received about 20 thousand doses of the vaccine produced by AstraZeneca. March 19 Moldova received 24.6 thousand doses Pfizer / BioNTech vaccines through the global COVAX initiative. According to the agency Bloomberg, 27.4 thousand vaccinations against coronavirus were made in the country (the population of Moldova is 2.6 million people).
Sputnik V vaccine was registered in Russia on August 11 last year. Russian President Vladimir Putin argued that it is effective, forms a stable immunity and has passed all the tests.
The vaccine has received criticism in the scientific community, as it was registered before the third phase of clinical trials. In Russia, they announced 95 percent efficiency… International magazine The Lancet wrote about efficiency at 91.6%.
At the same time, a number of Russian scientists noted that the accelerated approach to vaccine registration is contrary to scientific and ethical standards for drug development… Vaccinated Russians have complained of various side effects – fever, loss of smell, high blood pressure.
The Sputnik V vaccine has not been approved in the European Union. In Russia, mass vaccination with a domestic drug is underway. By data Russian Direct Investment Fund, as of March 23, the Sputnik V vaccine was approved for use in 56 countries.
European Commission President Ursula von der Leyen, speaking in Brussels on 17 February, expressed surprise that Russia offers Sputnik V to other countrieswithout vaccinating their own population.
– .
